• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过口服模拟表位疫苗主动诱导肿瘤特异性IgE抗体

Active induction of tumor-specific IgE antibodies by oral mimotope vaccination.

作者信息

Riemer Angelika B, Untersmayr Eva, Knittelfelder Regina, Duschl Albert, Pehamberger Hubert, Zielinski Christoph C, Scheiner Otto, Jensen-Jarolim Erika

机构信息

Departments of Pathophysiology, Dermatology, and Internal Medicine I, Medical University of Vienna, Vienna, Austria.

出版信息

Cancer Res. 2007 Apr 1;67(7):3406-11. doi: 10.1158/0008-5472.CAN-06-3758.

DOI:10.1158/0008-5472.CAN-06-3758
PMID:17409451
Abstract

A role of IgE antibodies in cancer surveillance has been implicated for a long time. Studies dealing with IgE antibodies directly targeted to tumor antigens have shown marked anticancer effects mediated by this antibody class. Thus, the basic function of IgE antibodies may be to control tumor growth. Thus far, cancer-specific IgE has only been applied passively. Consequently, the aim of this study was to establish an active vaccination protocol to induce tumor antigen-specific IgE antibodies, and to evaluate functional properties. We previously generated epitope mimics, so-called mimotopes, for the epitope recognized by the anti-HER-2 antibody trastuzumab. Upon i.p. immunizations, IgG antibodies with trastuzumab-like properties could be elicited. In the present study, we immunized BALB/c mice via the oral route with these trastuzumab mimotopes, under simultaneous neutralization and suppression of gastric acid. As shown in preceding experiments, this feeding regimen effectively induces Th2 immune responses. Oral immunizations with trastuzumab mimotopes under hypoacidic conditions indeed resulted in the formation of IgE antibodies towards the HER-2 antigen. Moreover, anti-HER-2 IgE-sensitized effector cells mediated SK-BR-3 target cell lysis in an antibody-dependent cytotoxicity assay. We conclude that directed and epitope-specific induction of IgE against tumor antigens is feasible with an oral mimotope vaccination regimen, and that these antibodies mediate anticancer effects.

摘要

长期以来,人们一直认为IgE抗体在癌症监测中发挥作用。针对直接靶向肿瘤抗原的IgE抗体的研究表明,这类抗体具有显著的抗癌作用。因此,IgE抗体的基本功能可能是控制肿瘤生长。到目前为止,癌症特异性IgE仅被被动应用。因此,本研究的目的是建立一种主动疫苗接种方案,以诱导肿瘤抗原特异性IgE抗体,并评估其功能特性。我们之前为抗HER-2抗体曲妥珠单抗识别的表位生成了表位模拟物,即所谓的模拟表位。经腹腔免疫后,可引发具有曲妥珠单抗样特性的IgG抗体。在本研究中,我们在中和并抑制胃酸的同时,通过口服途径用这些曲妥珠单抗模拟表位免疫BALB/c小鼠。如先前实验所示,这种喂养方案可有效诱导Th2免疫反应。在胃酸过少的条件下,用曲妥珠单抗模拟表位进行口服免疫确实导致了针对HER-2抗原的IgE抗体的形成。此外,在抗体依赖性细胞毒性试验中,抗HER-2 IgE致敏的效应细胞介导了SK-BR-3靶细胞的裂解。我们得出结论,通过口服模拟表位疫苗接种方案定向和表位特异性诱导针对肿瘤抗原的IgE是可行的,并且这些抗体介导抗癌作用。

相似文献

1
Active induction of tumor-specific IgE antibodies by oral mimotope vaccination.通过口服模拟表位疫苗主动诱导肿瘤特异性IgE抗体
Cancer Res. 2007 Apr 1;67(7):3406-11. doi: 10.1158/0008-5472.CAN-06-3758.
2
Generation of Peptide mimics of the epitope recognized by trastuzumab on the oncogenic protein Her-2/neu.生成曲妥珠单抗在致癌蛋白Her-2/neu上识别的表位的肽模拟物。
J Immunol. 2004 Jul 1;173(1):394-401. doi: 10.4049/jimmunol.173.1.394.
3
Inhibition of tumor cell growth by antibodies induced after vaccination with peptides derived from the extracellular domain of Her-2/neu.用源自Her-2/neu细胞外结构域的肽进行疫苗接种后诱导产生的抗体对肿瘤细胞生长的抑制作用。
Int J Cancer. 2003 Dec 20;107(6):976-83. doi: 10.1002/ijc.11485.
4
Vaccination with cetuximab mimotopes and biological properties of induced anti-epidermal growth factor receptor antibodies.西妥昔单抗模拟表位疫苗接种及诱导产生的抗表皮生长因子受体抗体的生物学特性
J Natl Cancer Inst. 2005 Nov 16;97(22):1663-70. doi: 10.1093/jnci/dji373.
5
Allergen mimotopes for 3-dimensional epitope search and induction of antibodies inhibiting human IgE.用于三维表位搜索及诱导抑制人IgE抗体的变应原模拟表位
FASEB J. 2000 Nov;14(14):2177-84. doi: 10.1096/fj.99-1000com.
6
Induction of IgG antibodies against the GD2 carbohydrate tumor antigen by vaccination with peptide mimotopes.通过用模拟表位肽疫苗接种诱导针对GD2碳水化合物肿瘤抗原的IgG抗体。
Eur J Immunol. 2006 May;36(5):1267-74. doi: 10.1002/eji.200535279.
7
Epitope-specific antibody response to IgE by mimotope immunization.通过模拟表位免疫对IgE的表位特异性抗体反应。
J Immunol. 1998 Apr 1;160(7):3315-21.
8
Oral anti-IgE immunization with epitope-displaying phage.用展示表位的噬菌体进行口服抗IgE免疫
Eur J Immunol. 2000 Jan;30(1):128-35. doi: 10.1002/1521-4141(200001)30:1<128::AID-IMMU128>3.0.CO;2-X.
9
Matching of trastuzumab (Herceptin) epitope mimics onto the surface of Her-2/neu--a new method of epitope definition.将曲妥珠单抗(赫赛汀)表位模拟物匹配到Her-2/neu表面——一种新的表位定义方法。
Mol Immunol. 2005 May;42(9):1121-4. doi: 10.1016/j.molimm.2004.11.003. Epub 2005 Jan 8.
10
Monovalent fusion proteins of IgE mimotopes are safe for therapy of type I allergy.IgE模拟表位的单价融合蛋白对I型过敏治疗是安全的。
FASEB J. 2001 Nov;15(13):2524-6. doi: 10.1096/fj.00-0888fje. Epub 2001 Sep 17.

引用本文的文献

1
The type 2 inflammatory response favors recognition of tumor antigens by IgE in breast cancer.2 型炎症反应有利于 IgE 识别乳腺癌中的肿瘤抗原。
Cancer Rep (Hoboken). 2024 Feb;7(2):e2002. doi: 10.1002/cnr2.2002.
2
Anti-cancer pro-inflammatory effects of an IgE antibody targeting the melanoma-associated antigen chondroitin sulfate proteoglycan 4.针对黑色素瘤相关抗原硫酸软骨素蛋白聚糖 4 的 IgE 抗体的抗癌抗炎作用。
Nat Commun. 2023 Apr 25;14(1):2192. doi: 10.1038/s41467-023-37811-3.
3
Antibodies specific for disease-associated antigens (DAA) expressed in non-malignant diseases reveal potential new tumor-associated antigens (TAA) for immunotherapy or immunoprevention.
针对非恶性疾病中表达的疾病相关抗原 (DAA) 的抗体揭示了潜在的新的肿瘤相关抗原 (TAA),可用于免疫治疗或免疫预防。
Semin Immunol. 2020 Feb;47:101394. doi: 10.1016/j.smim.2020.101394. Epub 2020 Apr 6.
4
IgE Antibodies: From Structure to Function and Clinical Translation.IgE抗体:从结构到功能及临床转化
Antibodies (Basel). 2019 Feb 22;8(1):19. doi: 10.3390/antib8010019.
5
Serum immunoglobulin E response as a marker for unfavorable prognosis following cholesteryl pullulan-MAGE A4 vaccination.血清免疫球蛋白E反应作为胆固醇基普鲁兰多糖-MAGE A4疫苗接种后预后不良的标志物。
Oncol Lett. 2018 Mar;15(3):3703-3711. doi: 10.3892/ol.2018.7767. Epub 2018 Jan 10.
6
Time-dependent transition of the immunoglobulin G subclass and immunoglobulin E response in cancer patients vaccinated with cholesteryl pullulan-melanoma antigen gene-A4 nanogel.接种胆固醇基普鲁兰多糖-黑色素瘤抗原基因A4纳米凝胶的癌症患者中免疫球蛋白G亚类和免疫球蛋白E反应的时间依赖性转变
Oncol Lett. 2016 Dec;12(6):4493-4504. doi: 10.3892/ol.2016.5253. Epub 2016 Oct 13.
7
Anti-Folate Receptor-α IgE but not IgG Recruits Macrophages to Attack Tumors via TNFα/MCP-1 Signaling.抗叶酸受体-α IgE而非IgG通过TNFα/MCP-1信号通路招募巨噬细胞攻击肿瘤。
Cancer Res. 2017 Mar 1;77(5):1127-1141. doi: 10.1158/0008-5472.CAN-16-1829. Epub 2017 Jan 17.
8
AllergoOncology - the impact of allergy in oncology: EAACI position paper.过敏与肿瘤学——过敏在肿瘤学中的影响:欧洲变态反应和临床免疫学会立场文件
Allergy. 2017 Jun;72(6):866-887. doi: 10.1111/all.13119. Epub 2017 Jan 23.
9
Proof of concept study with an HER-2 mimotope anticancer vaccine deduced from a novel AAV-mimotope library platform.基于新型腺相关病毒模拟表位文库平台推导的HER-2模拟表位抗癌疫苗的概念验证研究。
Oncoimmunology. 2016 Apr 21;5(7):e1171446. doi: 10.1080/2162402X.2016.1171446. eCollection 2016 Jul.
10
Elevated IgG4 in patient circulation is associated with the risk of disease progression in melanoma.患者循环中IgG4水平升高与黑色素瘤疾病进展风险相关。
Oncoimmunology. 2015 Jun 3;4(11):e1032492. doi: 10.1080/2162402X.2015.1032492. eCollection 2015 Nov.